Bank of Montreal Stock: Price, Forecast & Is BMO a Buy?

Bank of Montreal (TSX:BMO) is trading near CA$208, commanding a market cap of CA$145.84bn while sitting 61% below the broader market’s P/E average—a discount that catches the eye of value-conscious investors. Analysts lean cautiously constructive on the stock, with consensus targets clustering around CA$204 on the TSX and $163 on the NYSE.

Current Price (CAD): 208.04 · Market Cap: CA$145.84bn · P/E Ratio: 15.53 · Dividend Yield: 3.24% · 52 Week High: 154.48 USD

The key facts table below consolidates BMO’s core trading and valuation metrics for quick reference.

Is BMO good stock to buy?

The analyst picture for BMO leans cautiously constructive. On the TSX, 10 analysts track the stock with a Moderate Buy consensus and an average target of CA$204.43, according to Investing.com analyst estimates. The NYSE side shows 12 analysts with a similar Moderate Buy rating and an average price target of $163.00 — implying roughly 29% upside from the $126.55 base, per MarketBeat NYSE forecast.

Current performance metrics

BMO’s valuation metrics tell a nuanced story. The P/E ratio sits at 15.53 compared to a market average of 39.76, suggesting the stock trades at a discount, per MarketBeat TSX market data. Recent performance has been strong: 12.89% over the past month, 14.12% year-to-date, and a striking 65.94% over the past year, according to Simply Wall St valuation analysis. The dividend yield of 3.24% adds income appeal for longer-term holders.

Analyst ratings

The split across platforms is worth noting. Investing.com aggregates 14 analysts: 8 Buy, 6 Hold, and 1 Sell, per their consensus estimates page. Marketscreener tracks 15 analysts with an Outperform recommendation and an average target of CA$168.07, up from CA$164.22, per Marketscreener consensus data.

Individual firm actions give texture. RBC Capital set the high NYSE target at $163 as of October 3, 2025, according to Benzinga analyst ratings. Jefferies bumped the TSX target to CA$195 from CA$187 in late February 2025 while maintaining a Hold rating, per Marketscreener analyst updates. UBS also raised its TSX target to CA$206 during 2025.

Risk factors

No investment comes without caveats. The TSX consensus target of CA$204.43 sits slightly above the current price of CA$207.25 — suggesting analysts see the stock as roughly fairly priced, with a marginal 1% overvaluation, per Simply Wall St valuation article. Currency fluctuations between CAD and USD create pricing discrepancies across exchanges that can catch unwary investors.

What happened to Bank of Montreal stock?

BMO has staged an impressive recovery. The stock crested near CA$151 on the TSX over the past year, according to Investing.com market data. On the NYSE, BMO ranged between $109.02 and $151.08 over 52 weeks, with recent action hovering in the $128–$130 zone.

Recent price movements

The momentum story is real but nuanced. Simply Wall St reports BMO gained 12.89% in the past month and 14.12% year-to-date, while the one-year return hits nearly 66%, per their Simply Wall St performance data. That outperformance has brought the stock closer to — and in some cases above — analyst price targets that were set months earlier.

Key news events

Recent analyst adjustments tell the story of evolving sentiment. Jefferies upgraded its TSX target in February 2025, UBS followed suit sometime that year, and RBC Capital set its high $163 target in October 2025, per Benzinga analyst coverage. Marketscreener’s 15-analyst panel shows a consistent Outperform consensus, per their Marketscreener consensus page.

Splits and history

Bank of Montreal has maintained relatively stable trading characteristics on both exchanges. The TSX ticker BMO.TO and NYSE ticker BMO track the same underlying entity, with pricing differences reflecting CAD/USD exchange rates rather than fundamental divergence.

What this means: BMO has rewarded long-term holders handsomely over the past year, but recent gains have compressed the margin of safety relative to analyst targets.

What is the future price of BMO stock?

Forecasts cluster around two distinct ranges depending on the exchange and methodology. Alpha Spread’s analysis from 10 TSX analysts places the average target at CAD 211.36, with a low of CAD 195.94 and a high of CAD 235.20, per their Alpha Spread analyst estimates. MarketBeat TSX shows 10 analysts with an average target of C$201.33 and a low of C$145.00.

Forecasts from TipRanks

Price targets range significantly: TSX CAD 167–211 versus NYSE USD 128–163, according to MarketBeat TSX forecast and MarketBeat NYSE forecast. The currency-adjusted variance means TSX targets appear higher in local terms, but the percentage upside differs based on the base price.

Growth projections

Alpha Spread projects BMO’s revenue CAGR at 5% for the next three years versus 7% over the prior 13 years, while net income CAGR accelerates to 15% next three years from 6% historically, per their Alpha Spread growth data. EPS growth is pegged at 14% for fiscal 2026 and 10% for fiscal 2027, per Public.com earnings forecast.

Is BMO undervalued?

Two different models pull in opposite directions. Simply Wall St’s DCF analysis yields a fair value of CA$281.18 — implying a 26.3% discount at current prices around CA$207.25, per their Simply Wall St DCF valuation. That’s a substantial gap that suggests the stock has room to run if earnings materialize as projected.

Valuation analysis

The P/E ratio of 15.53 sits 61% below the market average of 39.76, per MarketBeat valuation comparison. By that yardstick, BMO looks cheap relative to broader equities. However, bank stocks traditionally trade at lower multiples due to regulatory capital requirements and cyclical loan loss exposure, so the discount isn’t automatically a bargain signal.

Comparison to peers

Within the Canadian Big Five, BMO’s valuation sits in the middle of the pack. The analyst consensus target of CA$204.43 is only 1% below current prices, per Simply Wall St peer comparison. Meanwhile, the DCF model at CA$281.18 suggests material upside — a 36.7% premium to consensus that hinges on execution and macroeconomic tailwinds.

The pattern: BMO looks cheap on trailing multiples, but whether that’s a buying opportunity or a value trap depends on whether net income growth hits the projected 15% CAGR.

Which Canadian bank stock is a strong buy?

Among Canadian bank stocks, BMO presents a mixed case. The dividend yield of 3.24% is competitive for income investors, and the recent 65.94% one-year return demonstrates momentum. But with analyst consensus targets clustering near current prices, the upside case requires faith in continued earnings expansion.

BMO vs peers

The Canadian banking sector includes Royal Bank (RY), Toronto-Dominion (TD), Scotiabank (BNS), CIBC (CM), and BMO. BMO’s P/E of 15.53 is lower than the group average, reflecting perhaps more cautious sentiment about its growth trajectory. The projected 15% net income CAGR could close that gap if achieved, per Alpha Spread sector analysis.

Outperformance potential

BMO’s recent performance has outpaced many peers on a percentage basis, but past returns don’t guarantee future results. For investors weighing BMO against the field, the DCF-implied 26.3% discount offers a more compelling entry point than the consensus target’s near-parity pricing suggests, per Simply Wall St investment thesis.

“Analysts see Bank of Montreal as roughly fairly priced, with the CA$207.25 share price close to their CA$204.43 target.”

— Simply Wall St valuation team

“Wall Street analysts forecast BMO stock price to rise over the next 12 months.”

— Alpha Spread market analysis

“The consensus among Wall Street analysts is that investors should ‘moderate buy’ BMO shares.”

— MarketBeat data aggregation team

Related reading: Hims and Hers Stock · Bank of Canada Surveys

While BMO carries a Moderate Buy rating with CA$204 target, its peer’s Scotiabank stock outlook offers a 4.4% yield and $76 price goal for comparison.

Frequently asked questions

For Canadian investors, BMO offers a credible income play with value-oriented valuation metrics. The P/E discount to the market suggests the stock isn’t expensive, but whether that discount narrows depends on whether the projected 15% net income CAGR materializes. US investors watching NYSE BMO see the $163 target implying roughly 29% upside — a more compelling math if the base price holds steady.